• Skip to primary navigation
  • Skip to main content

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Who is SAGES?
    • Leadership
    • SAGES Mission Statement
    • Advocacy
    • Committees
      • Request to Join a SAGES Committee
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Full Committee Rosters
      • SAGES Past Presidents
    • Donate to the SAGES Foundation
    • SAGES Store
    • Awards
      • George Berci Award
      • Pioneer in Surgical Endoscopy
      • Excellence In Clinical Care
      • International Ambassador
      • IRCAD Visiting Fellowship
      • Social Justice and Health Equity
      • Excellence in Community Surgery
      • Distinguished Service
      • Early Career Researcher
      • Researcher in Training
      • Jeff Ponsky Master Educator
      • Excellence in Medical Leadership
      • Barbara Berci Memorial Award
      • Brandeis Scholarship
      • Advocacy Summit
      • RAFT Annual Meeting Abstract Contest and Awards
    • “Unofficial” Logo Products
  • Meetings
    • NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call For Abstracts
      • 2026 Emerging Technology Call For Abstracts
    • CME Claim Form
    • Industry
      • Advertising Opportunities
    • Future Meetings
    • Related Meetings Calendar
  • Join SAGES!
    • Membership Benefits
    • Membership Applications
      • Active Membership
      • Affiliate Membership
      • Associate Active Membership
      • Candidate Membership
      • International Membership
      • Medical Student Membership
    • Member News
      • Member Spotlight
      • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Patient Information Brochures
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find a SAGES Member
  • Publications
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Patient Information Brochures
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • SCOPE – The SAGES Newsletter
    • COVID-19 Annoucements
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • OpiVoid.org
    • SAGES Video Subscription
    • SAGES.TV Video Library
    • Safe Cholecystectomy Program
      • Safe Cholecystectomy Didactic Modules
    • Masters Program
      • SAGES Facebook Program Collaboratives
      • Acute Care Surgery
      • Bariatric
      • Biliary
      • Colorectal
      • Flexible Endoscopy (upper or lower)
      • Foregut
      • Hernia
      • Robotics
    • Free Webinars For Residents
    • Educational Opportunities
    • HPB/Solid Organ Program
    • Fluorescence-Guided Surgery Course for Fellows
    • Fellows Career Development Course
    • Robotics Fellows Course
    • MIS Fellows Course
    • SMART Enhanced Recovery Program
    • SAGES OR SAFETY Video
    • SAGES Top 21 MIS Procedures
    • SAGES Pearls
    • SAGES Flexible Endoscopy 101
    • SAGES Tips & Tricks of the Top 21
  • Opportunities
    • Area of Concentrated Training Seal (ACT)-Advanced Flexible Endoscopy
    • SAGES Fellowship Recognition Opportunities
    • Multi-Society Foregut Fellowship Certification
    • SAGES Research Opportunities
    • Fundamentals of Laparoscopic Surgery
    • Fundamentals of Endoscopic Surgery
    • Fundamental Use of Surgical Energy
    • Job Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
  • OWLS / FLS
  • Log In

A Metastatic Colon Cancer Model Using Non-operative Trans-Anal Rectal Injection

(^) denotes superscript

Background: This study was conducted to develop a non-invasive orthotopic model for metastasis of colon and rectal cancer using a trans-anal approach that is non-operative, reproducible, and easy to perform. Currently, the most accurate orthotopic representation of metastatic human colon cancer is a cecal injection. The trans-anal model allows for further examination of systemic immune responses, tumor take, and onset of metastasis without prior surgical intervention.

Methods: Sixty (60) Balb/c mice were anesthetized and received gentle anal dilation using blunt tipped forceps at the anal opening. Using a 29 gauge syringe, murine colon cancer parental CT26 (CT26) or luciferase labeled CT26 (CT26-luc) cells were injected submucosally into the distal, posterior rectum (CT26 N=30 and CT26-luc N=30) at various concentrations: 2.5×10(^4), 1×10(^5), or 1×10(^6) in a volume of 50µL. All mice were injected using 100 x magnification. Tumor growth and metastatic development was monitored in CT26-luc (N=3) and grossly in CT26 (N=1) at 5 day intervals for 50 days. CT26-luc mice were anesthetized and injected with 150 µg/kg luciferin, then imaged with x-ray (15 second exposure) followed by luminescence (6 minute exposure) using the Kodak Molecular Imaging software. All remaining mice were sacrificed at post-injection day 50. The rectum, rectal wall, and liver were photographed, measured, processed for histology, and reviewed by a pathologist.

Results: The optimal concentration for metastasis and survival of mice was 2.5×10(^4) cells. Higher concentrations of CT26 or CT26-luc cells yielded higher mortality and did not result in metastasis. The overall success of tumor growth using the trans-anal rectal injection was 65%. Histology revealed that all tumors were poorly differentiated adenocarcinoma. Two mice (33%) from the 2.5×10(^4) CT26-luc group developed metastatic colonic adenocarcinoma to the liver at post-injection day 50. Luminescence monitoring of metastasis added no additional value.

Conclusion: Trans-anal rectal injection of colon cancer cells offers a non-operative orthotopic murine model for colon cancer that may lead to the development of metastasis. By using an orthotopic model that does not require abdominal surgery for implantation, more aspects of metastatic colon cancer can be evaluated without the influence of a previous abdominal incision. These results warrant more investigation into the metastatic capabilities of this model.


Session: Podium Presentation

Program Number: S050

444

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon

Related



  • Foundation
  • SAGES.TV
  • MyCME
  • Educational Activities

Copyright © 2025 Society of American Gastrointestinal and Endoscopic Surgeons